CLADRIPLAS: Does cladribine Target CNS plasma cells and reduce neuro-axonal damage in people with MS?
dc.contributor.author | Allen-Philbey, K | en_US |
dc.contributor.author | Andrews, M | en_US |
dc.contributor.author | Redha, I | en_US |
dc.contributor.author | Papachatzaki, M | en_US |
dc.contributor.author | Marta, M | en_US |
dc.contributor.author | Gnanapavan, S | en_US |
dc.contributor.author | Mathews, J | en_US |
dc.contributor.author | Turner, B | en_US |
dc.contributor.author | Giovannoni, G | en_US |
dc.contributor.author | Baker, D | en_US |
dc.contributor.author | Schmierer, K | en_US |
dc.date.accessioned | 2022-12-15T11:51:33Z | |
dc.date.issued | 2022 | en_US |
dc.identifier.issn | 1352-4585 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/83173 | |
dc.format.extent | 769 - 770 | en_US |
dc.title | CLADRIPLAS: Does cladribine Target CNS plasma cells and reduce neuro-axonal damage in people with MS? | en_US |
dc.type | Conference Proceeding | |
pubs.author-url | https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000866540803131&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 3_SUPPL | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 28 | en_US |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |